GP2-114 |
| Katalog-Nr.GC32650 |
GP2-114 (GP-2-114) erzeugt eine stromabhÄngige kardiovaskulÄre Wirkung, wenn es durch transdermale Iontophorese verabreicht wird.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 130783-39-0
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
GP2-114 (GP-2-114) produces current-dependent cardiovascular action when administered by transdermal iontophoresis.
A 50% mixture of the RR and RS distereoisomer forms of GP-2-128 (GP2-114) have the same pharmacologic profile as the pure RR distereoisomer[1].
[1]. Abou-Mohamed G, et al. J Cardiovasc Pharmacol. 1994 Mar;23(3):485-91. Integrative cardiovascular actions of a novel catecholamine, GP-2-128.
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *